Cargando…
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839296/ https://www.ncbi.nlm.nih.gov/pubmed/33504341 http://dx.doi.org/10.1186/s12943-021-01319-5 |
| _version_ | 1783643364090970112 |
|---|---|
| author | Cheli, Yann Tulic, Meri K. El Hachem, Najla Nottet, Nicolas Jacquel, Arnaud Gesson, Maeva Strub, Thomas Bille, Karine Picard-Gauci, Alexandra Montaudié, Henri Beranger, Guillaume E. Passeron, Thierry Close, Pierre Bertolotto, Corine Ballotti, Robert |
| author_facet | Cheli, Yann Tulic, Meri K. El Hachem, Najla Nottet, Nicolas Jacquel, Arnaud Gesson, Maeva Strub, Thomas Bille, Karine Picard-Gauci, Alexandra Montaudié, Henri Beranger, Guillaume E. Passeron, Thierry Close, Pierre Bertolotto, Corine Ballotti, Robert |
| author_sort | Cheli, Yann |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7839296 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78392962021-01-27 Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity Cheli, Yann Tulic, Meri K. El Hachem, Najla Nottet, Nicolas Jacquel, Arnaud Gesson, Maeva Strub, Thomas Bille, Karine Picard-Gauci, Alexandra Montaudié, Henri Beranger, Guillaume E. Passeron, Thierry Close, Pierre Bertolotto, Corine Ballotti, Robert Mol Cancer Correction BioMed Central 2021-01-27 /pmc/articles/PMC7839296/ /pubmed/33504341 http://dx.doi.org/10.1186/s12943-021-01319-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Cheli, Yann Tulic, Meri K. El Hachem, Najla Nottet, Nicolas Jacquel, Arnaud Gesson, Maeva Strub, Thomas Bille, Karine Picard-Gauci, Alexandra Montaudié, Henri Beranger, Guillaume E. Passeron, Thierry Close, Pierre Bertolotto, Corine Ballotti, Robert Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| title | Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| title_full | Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| title_fullStr | Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| title_full_unstemmed | Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| title_short | Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| title_sort | correction to: itgbl1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839296/ https://www.ncbi.nlm.nih.gov/pubmed/33504341 http://dx.doi.org/10.1186/s12943-021-01319-5 |
| work_keys_str_mv | AT cheliyann correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT tulicmerik correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT elhachemnajla correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT nottetnicolas correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT jacquelarnaud correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT gessonmaeva correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT strubthomas correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT billekarine correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT picardgaucialexandra correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT montaudiehenri correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT berangerguillaumee correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT passeronthierry correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT closepierre correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT bertolottocorine correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity AT ballottirobert correctiontoitgbl1isanewimmunomodulatorthatfavorsdevelopmentofmelanomatumorsbyinhibitingnaturalkillercellscytotoxicity |